Biomedical (basic)

Ended Definitive Contract Awarded Last action

Contract number
00278199809D278980001
Awardee
Awarding agency
Obligated
$31,962,264

Award facts

Contract value 100% obligated
$31,962,263.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Boston, MA 02114, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 16 · To DE-obligate remaining expiring FY2007 funds from can 8469685 in the amount of $333,886.30. -$333,886
Other Administrative Action 15 · To DE-obligate expiring FY2007 funds in part. A balance of FY07 will remain while desk audit is completed. -$535,561
Other Administrative Action 14 · To change contract completion date to 2/28/2011. $0
Other Administrative Action 13 $0
Other Administrative Action 12 $0
Additional Work (new agreement, FAR part 6 applies) 11 $6,000,971
Other Administrative Action 10 $0
Exercise an Option 9 $975,000
Funding Only Action 8 $750,000
Supplemental Agreement for work within scope 7 $0
Supplemental Agreement for work within scope 6 $6,420,678
Supplemental Agreement for work within scope 5 $798,647
Supplemental Agreement for work within scope 4 $5,193,509
Supplemental Agreement for work within scope 3 $5,285,781
Supplemental Agreement for work within scope 2 $0
Supplemental Agreement for work within scope 1 $4,548,024
Original award $2,859,101
Show all 17

About this award

This federal contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The General Hospital Corporation (doing business as Massachusetts General Hospital or MGH). The contract has a ceiling value of $31,962,263.70 and is a definitive, cost-type contract with no fee. The contract is for biomedical research services, and MGH leverages its expertise in areas such as cancer, infectious diseases, neurological disorders, and cardiovascular diseases to execute the work. As a subsidiary of the larger Partners Healthcare System, MGH frequently partners with academic institutions and serves as a subcontractor on NIH-funded projects. The contract does not have any set-aside designations.

MGH also holds an indefinite delivery contract with the Department of Veterans Affairs (VA) Veterans Health Administration, valued at up to $675,689 through 2028, to provide research and development services supporting the BrainGate ALS Hand Studies program. This single-award vehicle allows the VA to efficiently procure specialized genomic research services from MGH's parent organization, Partners Healthcare System, to support its precision medicine initiatives for veterans' healthcare.

Quick answers

Who was awarded contract 00278199809D278980001?

00278199809D278980001 was awarded to The General Hospital Corporation by National Institute on Drug Abuse (National Institutes of Health) on September 29, 1998.

How much is contract 00278199809D278980001 worth?

The government has obligated $31,962,264 on 00278199809D278980001.

Was contract 00278199809D278980001 competed?

The extent of competition for 00278199809D278980001 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award